Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Impact of natural menopause on multiple sclerosis: a multicentre study.

Baroncini D, Annovazzi PO, De Rossi N, Mallucci G, Torri Clerici V, Tonietti S, Mantero V, Ferrò MT, Messina MJ, Barcella V, La Mantia L, Ronzoni M, Barrilà C, Clerici R, Susani EL, Fusco ML, Chiveri L, Abate L, Ferraro O, Capra R, Colombo E, Confalonieri P, Zaffaroni M.

J Neurol Neurosurg Psychiatry. 2019 Jun 12. pii: jnnp-2019-320587. doi: 10.1136/jnnp-2019-320587. [Epub ahead of print]

PMID:
31189614
2.

Noncanonical Modulation of the eIF2 Pathway Controls an Increase in Local Translation during Neural Wiring.

Cagnetta R, Wong HH, Frese CK, Mallucci GR, Krijgsveld J, Holt CE.

Mol Cell. 2019 Feb 7;73(3):474-489.e5. doi: 10.1016/j.molcel.2018.11.013. Epub 2018 Dec 27.

3.

Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, Pastores GM, Rubinsztein DC, Nixon RA, Duchen MR, Mallucci GR, Kroemer G, Levine B, Eskelinen EL, Mochel F, Spedding M, Louis C, Martin OR, Millan MJ.

Nat Rev Drug Discov. 2018 Sep;17(9):660-688. doi: 10.1038/nrd.2018.109. Epub 2018 Aug 17. Review.

4.

Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21.

Restelli LM, Oettinghaus B, Halliday M, Agca C, Licci M, Sironi L, Savoia C, Hench J, Tolnay M, Neutzner A, Schmidt A, Eckert A, Mallucci G, Scorrano L, Frank S.

Cell Rep. 2018 Aug 7;24(6):1407-1414. doi: 10.1016/j.celrep.2018.07.023.

5.

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.

Mallucci G, Annovazzi P, Miante S, Torri-Clerici V, Matta M, La Gioia S, Cavarretta R, Mantero V, Costantini G, D'Ambrosio V, Zaffaroni M, Ghezzi A, Perini P, Rossi S, Bertolotto A, Rottoli MR, Rovaris M, Balgera R, Cavalla P, Montomoli C, Bergamaschi R.

J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.

PMID:
29948245
6.

Interferon-beta injection site reactions in patients with multiple sclerosis.

Maurelli M, Bergamaschi R, Antonini A, Fargnoli MC, Puma E, Mallucci G, Totaro R, Girolomoni G.

J Dermatolog Treat. 2018 Dec;29(8):831-834. doi: 10.1080/09546634.2018.1467539. Epub 2018 May 7. Review.

PMID:
29671656
7.

Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability.

Robinson SW, Bourgognon JM, Spiers JG, Breda C, Campesan S, Butcher A, Mallucci GR, Dinsdale D, Morone N, Mistry R, Smith TM, Guerra-Martin M, Challiss RAJ, Giorgini F, Steinert JR.

PLoS Biol. 2018 Apr 9;16(4):e2003611. doi: 10.1371/journal.pbio.2003611. eCollection 2018 Apr.

8.

Macrophage-Derived Extracellular Succinate Licenses Neural Stem Cells to Suppress Chronic Neuroinflammation.

Peruzzotti-Jametti L, Bernstock JD, Vicario N, Costa ASH, Kwok CK, Leonardi T, Booty LM, Bicci I, Balzarotti B, Volpe G, Mallucci G, Manferrari G, Donegà M, Iraci N, Braga A, Hallenbeck JM, Murphy MP, Edenhofer F, Frezza C, Pluchino S.

Cell Stem Cell. 2018 Mar 1;22(3):355-368.e13. doi: 10.1016/j.stem.2018.01.020. Epub 2018 Feb 22.

9.

The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway.

Hughes D, Mallucci GR.

FEBS J. 2019 Jan;286(2):342-355. doi: 10.1111/febs.14422. Epub 2018 Mar 11. Review.

PMID:
29476642
10.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Baroncini D, Zaffaroni M, Moiola L, Lorefice L, Fenu G, Iaffaldano P, Simone M, Fanelli F, Patti F, D'Amico E, Capobianco M, Bertolotto A, Gallo P, Margoni M, Miante S, Milani N, Amato MP, Righini I, Bellantonio P, Scandellari C, Costantino G, Scarpini E, Bergamaschi R, Mallucci G, Comi G, Ghezzi A.

Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24. Erratum in: Mult Scler. 2019 Jul 9;:1352458519862747.

PMID:
29363396
11.

Do MRI Structured Reports for Multiple Sclerosis Contain Adequate Information for Clinical Decision Making?

Alessandrino F, Pichiecchio A, Mallucci G, Ghione E, Romani A, Bergamaschi R, Bastianello S.

AJR Am J Roentgenol. 2018 Jan;210(1):24-29. doi: 10.2214/AJR.17.18451. Epub 2017 Sep 27.

PMID:
28952814
12.

Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI.

Bergamaschi R, Cortese A, Pichiecchio A, Berzolari FG, Borrelli P, Mallucci G, Bollati V, Romani A, Nosari G, Villa S, Montomoli C.

Mult Scler. 2018 Oct;24(12):1578-1584. doi: 10.1177/1352458517726866. Epub 2017 Aug 14.

PMID:
28805546
13.

Fine-tuning PERK signaling for neuroprotection.

Halliday M, Hughes D, Mallucci GR.

J Neurochem. 2017 Sep;142(6):812-826. doi: 10.1111/jnc.14112. Epub 2017 Aug 8. Review. Erratum in: J Neurochem. 2019 Jun;149(5):699.

14.

Reply: Trazodone to change the risk of neurodegeneration: bedside to bench.

Halliday M, Mallucci GR.

Brain. 2017 Aug 1;140(8):e48. doi: 10.1093/brain/awx150. No abstract available.

PMID:
28641370
15.

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.

Halliday M, Radford H, Zents KAM, Molloy C, Moreno JA, Verity NC, Smith E, Ortori CA, Barrett DA, Bushell M, Mallucci GR.

Brain. 2017 Jun 1;140(6):1768-1783. doi: 10.1093/brain/awx074.

16.

What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question.

Pistono C, Osera C, Boiocchi C, Mallucci G, Cuccia M, Bergamaschi R, Pascale A.

Pharmacol Res. 2017 Jun;120:279-293. doi: 10.1016/j.phrs.2017.03.025. Epub 2017 Apr 8. Review.

PMID:
28396093
17.

RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3.

Bastide A, Peretti D, Knight JR, Grosso S, Spriggs RV, Pichon X, Sbarrato T, Roobol A, Roobol J, Vito D, Bushell M, von der Haar T, Smales CM, Mallucci GR, Willis AE.

Curr Biol. 2017 Mar 6;27(5):638-650. doi: 10.1016/j.cub.2017.01.047. Epub 2017 Feb 23.

18.

M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss.

Bradley SJ, Bourgognon JM, Sanger HE, Verity N, Mogg AJ, White DJ, Butcher AJ, Moreno JA, Molloy C, Macedo-Hatch T, Edwards JM, Wess J, Pawlak R, Read DJ, Sexton PM, Broad LM, Steinert JR, Mallucci GR, Christopoulos A, Felder CC, Tobin AB.

J Clin Invest. 2017 Feb 1;127(2):487-499. doi: 10.1172/JCI87526. Epub 2016 Dec 19.

19.

Heat shock protein 70-hom gene polymorphism and protein expression in multiple sclerosis.

Boiocchi C, Monti MC, Osera C, Mallucci G, Pistono C, Ferraro OE, Nosari G, Romani A, Cuccia M, Govoni S, Pascale A, Montomoli C, Bergamaschi R.

J Neuroimmunol. 2016 Sep 15;298:189-93. doi: 10.1016/j.jneuroim.2016.07.011. Epub 2016 Jul 15.

PMID:
27609295
20.

Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease.

Celardo I, Costa AC, Lehmann S, Jones C, Wood N, Mencacci NE, Mallucci GR, Loh SH, Martins LM.

Cell Death Dis. 2016 Jun 23;7(6):e2271. doi: 10.1038/cddis.2016.173.

21.

The unfolded protein response: mechanisms and therapy of neurodegeneration.

Smith HL, Mallucci GR.

Brain. 2016 Aug;139(Pt 8):2113-21. doi: 10.1093/brain/aww101. Epub 2016 May 11. Review.

22.

The UPR and synaptic dysfunction in neurodegeneration.

Freeman OJ, Mallucci GR.

Brain Res. 2016 Oct 1;1648(Pt B):530-537. doi: 10.1016/j.brainres.2016.03.029. Epub 2016 Mar 26. Review.

PMID:
27021956
23.

Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesis.

Knight JR, Bastide A, Peretti D, Roobol A, Roobol J, Mallucci GR, Smales CM, Willis AE.

RNA. 2016 Apr;22(4):623-35. doi: 10.1261/rna.054411.115. Epub 2016 Feb 8.

24.

PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.

Radford H, Moreno JA, Verity N, Halliday M, Mallucci GR.

Acta Neuropathol. 2015 Nov;130(5):633-42. doi: 10.1007/s00401-015-1487-z. Epub 2015 Oct 8.

25.

Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling.

Tambalo S, Peruzzotti-Jametti L, Rigolio R, Fiorini S, Bontempi P, Mallucci G, Balzarotti B, Marmiroli P, Sbarbati A, Cavaletti G, Pluchino S, Marzola P.

J Neurosci. 2015 Jul 8;35(27):10088-100. doi: 10.1523/JNEUROSCI.0540-15.2015.

26.

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

Bergamaschi R, Montomoli C, Mallucci G, Lugaresi A, Izquierdo G, Grand'Maison F, Duquette P, Shaygannejad V, Alroughani R, Grammond P, Boz C, Iuliano G, Zwanikken C, Petersen T, Lechner-Scott J, Hupperts R, Butzkueven H, Pucci E, Oreja-Guevara C, Cristiano E, Pia Amato MP, Havrdova E, Fernandez-Bolanos R, Spelman T, Trojano M.

Eur J Neurol. 2015 Jun;22(6):981-9. doi: 10.1111/ene.12696. Epub 2015 Mar 25.

PMID:
25808578
27.

The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

Mallucci G, Peruzzotti-Jametti L, Bernstock JD, Pluchino S.

Prog Neurobiol. 2015 Apr;127-128:1-22. doi: 10.1016/j.pneurobio.2015.02.003. Epub 2015 Mar 21. Review.

28.

Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity.

Halliday M, Radford H, Sekine Y, Moreno J, Verity N, le Quesne J, Ortori CA, Barrett DA, Fromont C, Fischer PM, Harding HP, Ron D, Mallucci GR.

Cell Death Dis. 2015 Mar 5;6:e1672. doi: 10.1038/cddis.2015.49.

29.

RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration.

Peretti D, Bastide A, Radford H, Verity N, Molloy C, Martin MG, Moreno JA, Steinert JR, Smith T, Dinsdale D, Willis AE, Mallucci GR.

Nature. 2015 Feb 12;518(7538):236-9. doi: 10.1038/nature14142. Epub 2015 Jan 14.

30.

Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory.

Halliday M, Mallucci GR.

Neuropathol Appl Neurobiol. 2015 Jun;41(4):414-27. doi: 10.1111/nan.12211. Review.

31.

Targeting synaptic pathology with a novel affinity mass spectrometry approach.

Brinkmalm A, Brinkmalm G, Honer WG, Moreno JA, Jakobsson J, Mallucci GR, Zetterberg H, Blennow K, Öhrfelt A.

Mol Cell Proteomics. 2014 Oct;13(10):2584-92. doi: 10.1074/mcp.M114.040113. Epub 2014 Jun 27.

32.

Prions: generation and spread versus neurotoxicity.

Halliday M, Radford H, Mallucci GR.

J Biol Chem. 2014 Jul 18;289(29):19862-8. doi: 10.1074/jbc.R114.568477. Epub 2014 May 23. Review.

33.

The role of the immune system in central nervous system plasticity after acute injury.

Peruzzotti-Jametti L, Donegá M, Giusto E, Mallucci G, Marchetti B, Pluchino S.

Neuroscience. 2014 Dec 26;283:210-221. doi: 10.1016/j.neuroscience.2014.04.036. Epub 2014 Apr 29. Review.

34.

Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease.

Tufi R, Gandhi S, de Castro IP, Lehmann S, Angelova PR, Dinsdale D, Deas E, Plun-Favreau H, Nicotera P, Abramov AY, Willis AE, Mallucci GR, Loh SH, Martins LM.

Nat Cell Biol. 2014 Feb;16(2):157-66. doi: 10.1038/ncb2901. Epub 2014 Jan 19.

35.

miRNAs-19b, -29b-2* and -339-5p show an early and sustained up-regulation in ischemic models of stroke.

Dhiraj DK, Chrysanthou E, Mallucci GR, Bushell M.

PLoS One. 2013 Dec 20;8(12):e83717. doi: 10.1371/journal.pone.0083717. eCollection 2013.

36.

Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice.

Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM, Ortori CA, Willis AE, Fischer PM, Barrett DA, Mallucci GR.

Sci Transl Med. 2013 Oct 9;5(206):206ra138. doi: 10.1126/scitranslmed.3006767.

37.

Targeting the unfolded protein response in neurodegeneration: A new approach to therapy.

Halliday M, Mallucci GR.

Neuropharmacology. 2014 Jan;76 Pt A:169-74. doi: 10.1016/j.neuropharm.2013.08.034. Epub 2013 Sep 10. Review.

PMID:
24035917
38.

Spreading proteins in neurodegeneration: where do they take us?

Mallucci G.

Brain. 2013 Apr;136(Pt 4):994-5. doi: 10.1093/brain/awt072. Epub 2013 Mar 21. No abstract available.

PMID:
23518708
39.

Targeted knock-down of cellular prion protein expression in myelinating Schwann cells does not alter mouse prion pathogenesis.

Halliez S, Chesnais N, Mallucci G, Vilotte M, Langevin C, Jaumain E, Laude H, Vilotte JL, Béringue V.

J Gen Virol. 2013 Jun;94(Pt 6):1435-40. doi: 10.1099/vir.0.049619-0. Epub 2013 Feb 6.

PMID:
23388201
40.

Sustained translational repression by eIF2α-P mediates prion neurodegeneration.

Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, Halliday M, Morgan J, Dinsdale D, Ortori CA, Barrett DA, Tsaytler P, Bertolotti A, Willis AE, Bushell M, Mallucci GR.

Nature. 2012 May 6;485(7399):507-11. doi: 10.1038/nature11058. Erratum in: Nature.2014 Jul 17;511(7509):370.

41.

Anti-aquaporin-4 antibody-positive recurrent isolated optic neuritis and primary Sjögren's syndrome.

Mallucci G, Franciotta D, Romani A, Ceroni M, Bergamaschi R.

J Neurol. 2012 Aug;259(8):1740-1. doi: 10.1007/s00415-012-6434-5. Epub 2012 Feb 11. No abstract available.

PMID:
22327571
42.

Rescuing neurons in prion disease.

Verity NC, Mallucci GR.

Biochem J. 2011 Jan 1;433(1):19-29. doi: 10.1042/BJ20101323. Review.

PMID:
21158739
43.

Dysfunction and recovery of synapses in prion disease: implications for neurodegeneration.

Moreno JA, Mallucci GR.

Biochem Soc Trans. 2010 Apr;38(2):482-7. doi: 10.1042/BST0380482. Review.

PMID:
20298207
44.

Can mutations of prion protein shed light on its normal function?

Mallucci GR.

J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1303. doi: 10.1136/jnnp.2009.172874. No abstract available.

PMID:
19917814
45.

Prion neurodegeneration: starts and stops at the synapse.

Mallucci GR.

Prion. 2009 Oct-Dec;3(4):195-201. Epub 2009 Oct 2. Review.

46.

The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.

Radford HE, Mallucci GR.

Curr Issues Mol Biol. 2010;12(2):119-27. Epub 2009 Sep 18. Review.

47.

RNAi for the treatment of prion disease: a window for intervention in neurodegeneration?

White MD, Mallucci GR.

CNS Neurol Disord Drug Targets. 2009 Nov;8(5):342-52. Review.

PMID:
19702576
48.

Therapy for prion diseases: Insights from the use of RNA interference.

White MD, Mallucci GR.

Prion. 2009 Jul-Sep;3(3):121-8. Epub 2009 Jul 16. Review.

49.

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.

White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10238-43. doi: 10.1073/pnas.0802759105. Epub 2008 Jul 16.

50.

Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.

Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J.

Neuron. 2007 Feb 1;53(3):325-35.

Supplemental Content

Loading ...
Support Center